Top

Allergy, Asthma & Clinical Immunology

Published in:

Open Access 01-12-2016 | Letter to the Editor

Evaluation of circulating vascular endothelial growth factor and its soluble receptors in patients suffering from persistent allergic rhinitis

Authors: E. Koczy-Baron, A. Grzanka, J. Jochem, R. Gawlik, A. Kasperska-Zajac

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2016

Abstract

Background

Overexpression and enhanced release of vascular endothelial growth factor (VEGF) have been detected in various types of allergic inflammation, including asthma.

Aim

To further evaluate the pattern of systemic release of VEGF in atopic allergy, free circulating VEGF was measured in patients with persistent allergic rhinitis (PAR).

Methods

The concentrations of VEGF and its soluble receptors (sVEGF-R1 and VEGF-R2) in plasma were measured in patients with PAR sensitized to house dust mites and the healthy subjects.

Results

No significant differences were found between PAR patients and healthy subjects with respect to plasma levels of VEGF and its receptors.

Conclusions

It seems that free circulating VEGF may not be elevated in PAR patients. Moreover, on the basis of the present study as well as the earlier ones, it appears likely that systemic release of VEGF varies among patients with distinct clinical manifestation of atopy; may depend on severity/activity and the extent of inflammatory response.

Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 2005;109:227–41.CrossRef

Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, Elias JA. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–103.CrossRefPubMedPubMedCentral

Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 1990;50:1774–8.PubMed

Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast-cell migration. Blood. 1995;86:2488–93.PubMed

Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol. 1997;17:70–7.CrossRefPubMed

Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP, Dvorak HF, Galli SJ. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med. 1998;188:1135–45.CrossRefPubMedPubMedCentral

Capetandes A, Zhuang M, Haque FN, Xie L, Frieri M. Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract. Allergy Asthma Proc. 2007;28:324–30.CrossRefPubMed

Feistritzer C, Kaneider NC, Sturn DH, Mosheimer BA, Kähler CM, Wiedermann CJ. Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. Am J Respir Cell Mol Biol. 2004;30:729–35.CrossRefPubMed

Koczy-Baron E, Jochem J, Kasperska-Zajac A. Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation. Inflamm Res. 2012;61:1405–9.CrossRefPubMedPubMedCentral

10.

Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation. 2007;30:161–6.CrossRefPubMed

11.

Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy. 2003;33:595–9.CrossRefPubMed

12.

Lee KY, Lee KS, Park SJ, Kim SR, Min KH, Choe YH, Lee YC. Clinical significance of plasma and serum vascular endothelial growth factor in asthma. J Asthma. 2008;45:735–9.CrossRefPubMed

13.

Matsune S, Ohori J, Yoshifuku K, Kurono Y. Effect of vascular endothelial growth factor on nasal vascular permeability. Laryngoscope. 2010;120:844–8.CrossRefPubMed

14.

Matsune S, Ohori J, Sun D, Yoshifuku K, Fukuiwa T, Kurono Y. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis. Am J Rhinol. 2008;22:365–70.CrossRefPubMed

15.

Benson M, Carlsson B, Carlsson LM, Wennergren G, Cardell LO. Increased expression of vascular endothelial growth factor-A in seasonal allergic rhinitis. Cytokine. 2002;20:268–73.CrossRefPubMed

16.

Ciprandi G, Murdaca G, Colombo BM, De Amici M, Marseglia GL. Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus. Hum Immunol. 2008;69:510–2.CrossRefPubMed

17.

Ciprandi G, Colombo BM, Murdaca G, De Amici M. Serum vascular endothelial growth factor and sublingual immunotherapy. Allergy. 2008;63:945–6.CrossRefPubMed

18.

Wynendaele W, Derua R, Hoylaerts MF, Pawinski A, Waelkens E, de Bruijn EA, Paridaens R, Merlevede W, van Oosterom AT. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol. 1999;10:965–71.CrossRefPubMed

19.

Kasperska-Zajac A, Brzoza Z, Rogala B. Seasonal changes in platelet activity in patients with pollen-induced seasonal allergic rhinitis and seasonal asthma. J Asthma. 2008;45:485–7.CrossRefPubMed

20.

Kasperska-Zajac A, Rogala B. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin Exp Allergy. 2005;35:1462–5.CrossRefPubMed

21.

Kasperska-Zajac A, Rogala B, Nowakowski M. Assessment of platelet activity, expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria. Exp Dermatol. 2005;14:515–8.CrossRefPubMed

22.

Kasperska-Zajac A, Rogala B. Platelet function in anaphylaxis. J Invest Allergol Clin Immunol. 2006;16:1–4.

Title: Evaluation of circulating vascular endothelial growth factor and its soluble receptors in patients suffering from persistent allergic rhinitis
Authors: E. Koczy-Baron
A. Grzanka
J. Jochem
R. Gawlik
A. Kasperska-Zajac
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Allergy, Asthma & Clinical Immunology / Issue 1/2016
Electronic ISSN: 1710-1492
DOI: https://doi.org/10.1186/s13223-016-0124-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Evaluation of circulating vascular endothelial growth factor and its soluble receptors in patients suffering from persistent allergic rhinitis

Abstract

Background

Aim

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Clinical and immuno-proteomic approach on Lantana camara pollen allergy—a major health hazard

Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis

A rare nonsynonymous variant in the lipid metabolic gene HELZ2 related to primary biliary cirrhosis in Chinese Han

Maternal serum but not breast milk IL-5, IL-6, and IL-13 immune markers are associated with scratching among infants

Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence

Aspergillus march: from ABPA to aspergilloma to subacute invasive aspergillosis